Biologics Market Research Report by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies, Recombinant Hormones/Proteins, and Vaccines), by Application (Autoimmune Diseases, Cancer, Infectious Diseases, and Rare Diseases) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Biologics Market is expected to grow from USD 247,824.45 Million in 2020 to USD 306,788.28 Million by the end of 2025.
2. The Global Biologics Market is expected to grow from EUR 217,297.18 Million in 2020 to EUR 268,997.79 Million by the end of 2025.
3. The Global Biologics Market is expected to grow from GBP 193,177.67 Million in 2020 to GBP 239,139.62 Million by the end of 2025.
4. The Global Biologics Market is expected to grow from JPY 26,449,149.07 Million in 2020 to JPY 32,742,083.49 Million by the end of 2025.
5. The Global Biologics Market is expected to grow from AUD 359,874.06 Million in 2020 to AUD 445,497.38 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Biologics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Biologics Market studied across Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies, Recombinant Hormones/Proteins, and Vaccines. The Monoclonal Antibodies further studied across Diagnostic and Therapeutic.
Based on Application, the Biologics Market studied across Autoimmune Diseases, Cancer, Infectious Diseases, and Rare Diseases.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Biologics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Biologics Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Biologics Market including AbbVie Inc., Allergan, Amgen Inc, Apogenix, AstraZeneca, Bayer AG, Biocon, BioMarin Pharmaceutical, Celltrion, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gangagen, GlaxoSmithKline PLC, GSK group of companies, Johnson & Johnson, Medexus Pharma, Merck & Co., Novo Nordisk AS, Pfizer Inc., Precision Biologics, Inc., Samsung BioLogics, Sanofi SA, Theratome Bio, Tubulis Technologies, and Vaximm.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Biologics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Market?
4. What is the competitive strategic window for opportunities in the Global Biologics Market?
5. What are the technology trends and regulatory frameworks in the Global Biologics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Biologics Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Biologics Market is expected to grow from USD 247,824.45 Million in 2020 to USD 306,788.28 Million by the end of 2025.
2. The Global Biologics Market is expected to grow from EUR 217,297.18 Million in 2020 to EUR 268,997.79 Million by the end of 2025.
3. The Global Biologics Market is expected to grow from GBP 193,177.67 Million in 2020 to GBP 239,139.62 Million by the end of 2025.
4. The Global Biologics Market is expected to grow from JPY 26,449,149.07 Million in 2020 to JPY 32,742,083.49 Million by the end of 2025.
5. The Global Biologics Market is expected to grow from AUD 359,874.06 Million in 2020 to AUD 445,497.38 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Biologics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Biologics Market studied across Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies, Recombinant Hormones/Proteins, and Vaccines. The Monoclonal Antibodies further studied across Diagnostic and Therapeutic.
Based on Application, the Biologics Market studied across Autoimmune Diseases, Cancer, Infectious Diseases, and Rare Diseases.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Biologics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Biologics Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Biologics Market including AbbVie Inc., Allergan, Amgen Inc, Apogenix, AstraZeneca, Bayer AG, Biocon, BioMarin Pharmaceutical, Celltrion, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gangagen, GlaxoSmithKline PLC, GSK group of companies, Johnson & Johnson, Medexus Pharma, Merck & Co., Novo Nordisk AS, Pfizer Inc., Precision Biologics, Inc., Samsung BioLogics, Sanofi SA, Theratome Bio, Tubulis Technologies, and Vaximm.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Biologics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Market?
4. What is the competitive strategic window for opportunities in the Global Biologics Market?
5. What are the technology trends and regulatory frameworks in the Global Biologics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Biologics Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Application Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Attractive investment in the market from players across value chain
5.1.1.2. Rising prevalence of chronic diseases
5.1.1.3. Patent loss of leading biologic drugs
5.1.1.4. Availability of advanced diagnostics and rising government initiatives in healthcare
5.1.2. Restraints
5.1.2.1. Stringent regulatory process coupled with high capital investment
5.1.3. Opportunities
5.1.3.1. Higher acceptability for innovative therapies
5.1.3.2. Technological advancements in research and development across the globe
5.1.4. Challenges
5.1.4.1. Tightly controlled atmospheric conditions and maintained production process
5.1.4.2. Cost associated with access of biologics
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL BIOLOGICS MARKET, BY PRODUCT
6.1. Introduction
6.2. Cellular Based Biologics
6.3. Gene Based Biologics
6.4. Monoclonal Antibodies
6.4.1. Diagnostic
6.4.1.1. Biochemical Analysis
6.4.1.2. Diagnostic Imaging
6.4.2. Therapeutic
6.4.2.1. Direct MAB Agents
6.4.2.2. Targeting MAB Agents
6.5. Recombinant Hormones/Proteins
6.6. Vaccines
7. GLOBAL BIOLOGICS MARKET, BY APPLICATION
7.1. Introduction
7.2. Autoimmune Diseases
7.3. Cancer
7.4. Infectious Diseases
7.5. Rare Diseases
8. AMERICAS BIOLOGICS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC BIOLOGICS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. AbbVie Inc.
12.2. Allergan
12.3. Amgen Inc
12.4. Apogenix
12.5. AstraZeneca
12.6. Bayer AG
12.7. Biocon
12.8. BioMarin Pharmaceutical
12.9. Celltrion
12.10. Eli Lilly and Company
12.11. F. Hoffmann-La Roche AG
12.12. Gangagen
12.13. GlaxoSmithKline PLC
12.14. GSK group of companies
12.15. Johnson & Johnson
12.16. Medexus Pharma
12.17. Merck & Co.
12.18. Novo Nordisk AS
12.19. Pfizer Inc.
12.20. Precision Biologics, Inc.
12.21. Samsung BioLogics
12.22. Sanofi SA
12.23. Theratome Bio
12.24. Tubulis Technologies
12.25. Vaximm
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Application Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Attractive investment in the market from players across value chain
5.1.1.2. Rising prevalence of chronic diseases
5.1.1.3. Patent loss of leading biologic drugs
5.1.1.4. Availability of advanced diagnostics and rising government initiatives in healthcare
5.1.2. Restraints
5.1.2.1. Stringent regulatory process coupled with high capital investment
5.1.3. Opportunities
5.1.3.1. Higher acceptability for innovative therapies
5.1.3.2. Technological advancements in research and development across the globe
5.1.4. Challenges
5.1.4.1. Tightly controlled atmospheric conditions and maintained production process
5.1.4.2. Cost associated with access of biologics
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL BIOLOGICS MARKET, BY PRODUCT
6.1. Introduction
6.2. Cellular Based Biologics
6.3. Gene Based Biologics
6.4. Monoclonal Antibodies
6.4.1. Diagnostic
6.4.1.1. Biochemical Analysis
6.4.1.2. Diagnostic Imaging
6.4.2. Therapeutic
6.4.2.1. Direct MAB Agents
6.4.2.2. Targeting MAB Agents
6.5. Recombinant Hormones/Proteins
6.6. Vaccines
7. GLOBAL BIOLOGICS MARKET, BY APPLICATION
7.1. Introduction
7.2. Autoimmune Diseases
7.3. Cancer
7.4. Infectious Diseases
7.5. Rare Diseases
8. AMERICAS BIOLOGICS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC BIOLOGICS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. AbbVie Inc.
12.2. Allergan
12.3. Amgen Inc
12.4. Apogenix
12.5. AstraZeneca
12.6. Bayer AG
12.7. Biocon
12.8. BioMarin Pharmaceutical
12.9. Celltrion
12.10. Eli Lilly and Company
12.11. F. Hoffmann-La Roche AG
12.12. Gangagen
12.13. GlaxoSmithKline PLC
12.14. GSK group of companies
12.15. Johnson & Johnson
12.16. Medexus Pharma
12.17. Merck & Co.
12.18. Novo Nordisk AS
12.19. Pfizer Inc.
12.20. Precision Biologics, Inc.
12.21. Samsung BioLogics
12.22. Sanofi SA
12.23. Theratome Bio
12.24. Tubulis Technologies
12.25. Vaximm
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL BIOLOGICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL BIOLOGICS MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL BIOLOGICS MARKET SIZE, BY RARE DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. BRAZIL BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. BRAZIL BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CANADA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CANADA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. MEXICO BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. UNITED STATES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. AUSTRALIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. AUSTRALIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. CHINA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. CHINA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. INDIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. INDIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. INDONESIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. INDONESIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. JAPAN BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. JAPAN BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. MALAYSIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. MALAYSIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. PHILIPPINES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. PHILIPPINES BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. SOUTH KOREA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. SOUTH KOREA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. THAILAND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. THAILAND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. FRANCE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. FRANCE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. GERMANY BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. GERMANY BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. ITALY BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. ITALY BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. NETHERLANDS BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. NETHERLANDS BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. QATAR BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. QATAR BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. RUSSIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. RUSSIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. SPAIN BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. SPAIN BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. GLOBAL BIOLOGICS MARKET: SCORES
TABLE 81. GLOBAL BIOLOGICS MARKET: BUSINESS STRATEGY
TABLE 82. GLOBAL BIOLOGICS MARKET: PRODUCT SATISFACTION
TABLE 83. GLOBAL BIOLOGICS MARKET: RANKING
TABLE 84. GLOBAL BIOLOGICS MARKET: MERGER & ACQUISITION
TABLE 85. GLOBAL BIOLOGICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 86. GLOBAL BIOLOGICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 87. GLOBAL BIOLOGICS MARKET: INVESTMENT & FUNDING
TABLE 88. GLOBAL BIOLOGICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 89. GLOBAL BIOLOGICS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL BIOLOGICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL BIOLOGICS MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL BIOLOGICS MARKET SIZE, BY RARE DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. BRAZIL BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. BRAZIL BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CANADA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CANADA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. MEXICO BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. UNITED STATES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. AUSTRALIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. AUSTRALIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. CHINA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. CHINA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. INDIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. INDIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. INDONESIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. INDONESIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. JAPAN BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. JAPAN BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. MALAYSIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. MALAYSIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. PHILIPPINES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. PHILIPPINES BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. SOUTH KOREA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. SOUTH KOREA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. THAILAND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. THAILAND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. FRANCE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. FRANCE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. GERMANY BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. GERMANY BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. ITALY BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. ITALY BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. NETHERLANDS BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. NETHERLANDS BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. QATAR BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. QATAR BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. RUSSIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. RUSSIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. SPAIN BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. SPAIN BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. GLOBAL BIOLOGICS MARKET: SCORES
TABLE 81. GLOBAL BIOLOGICS MARKET: BUSINESS STRATEGY
TABLE 82. GLOBAL BIOLOGICS MARKET: PRODUCT SATISFACTION
TABLE 83. GLOBAL BIOLOGICS MARKET: RANKING
TABLE 84. GLOBAL BIOLOGICS MARKET: MERGER & ACQUISITION
TABLE 85. GLOBAL BIOLOGICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 86. GLOBAL BIOLOGICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 87. GLOBAL BIOLOGICS MARKET: INVESTMENT & FUNDING
TABLE 88. GLOBAL BIOLOGICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 89. GLOBAL BIOLOGICS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL BIOLOGICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BIOLOGICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL BIOLOGICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL BIOLOGICS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL BIOLOGICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 14. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2025
FIGURE 16. GLOBAL BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 28. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2025
FIGURE 30. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL BIOLOGICS MARKET SIZE, BY CANCER, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL BIOLOGICS MARKET SIZE, BY RARE DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 34. AMERICAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 35. AMERICAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 37. ARGENTINA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. BRAZIL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. CANADA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. MEXICO BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. UNITED STATES BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 43. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 45. AUSTRALIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. CHINA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. INDIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. INDONESIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. JAPAN BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. MALAYSIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. PHILIPPINES BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. SOUTH KOREA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. THAILAND BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 57. FRANCE BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. GERMANY BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. ITALY BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. NETHERLANDS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. QATAR BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. RUSSIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. SPAIN BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. GLOBAL BIOLOGICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 69. GLOBAL BIOLOGICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 70. GLOBAL BIOLOGICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOLOGICS MARKET, BY TYPE
FIGURE 1. GLOBAL BIOLOGICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BIOLOGICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL BIOLOGICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL BIOLOGICS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL BIOLOGICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 14. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2025
FIGURE 16. GLOBAL BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 28. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2025
FIGURE 30. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL BIOLOGICS MARKET SIZE, BY CANCER, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL BIOLOGICS MARKET SIZE, BY RARE DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 34. AMERICAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 35. AMERICAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 37. ARGENTINA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. BRAZIL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. CANADA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. MEXICO BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. UNITED STATES BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 43. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 45. AUSTRALIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. CHINA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. INDIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. INDONESIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. JAPAN BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. MALAYSIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. PHILIPPINES BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. SOUTH KOREA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. THAILAND BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 57. FRANCE BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. GERMANY BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. ITALY BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. NETHERLANDS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. QATAR BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. RUSSIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. SPAIN BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. GLOBAL BIOLOGICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 69. GLOBAL BIOLOGICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 70. GLOBAL BIOLOGICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOLOGICS MARKET, BY TYPE
